These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1257 related items for PubMed ID: 28004121

  • 1. Pifithrin-μ is efficacious against non-small cell lung cancer via inhibition of heat shock protein 70.
    Zhou Y, Ma J, Zhang J, He L, Gong J, Long C.
    Oncol Rep; 2017 Jan; 37(1):313-322. PubMed ID: 28004121
    [Abstract] [Full Text] [Related]

  • 2. Suppression of HSP70 expression sensitizes NSCLC cell lines to TRAIL-induced apoptosis by upregulating DR4 and DR5 and downregulating c-FLIP-L expressions.
    Zhuang H, Jiang W, Zhang X, Qiu F, Gan Z, Cheng W, Zhang J, Guan S, Tang B, Huang Q, Wu X, Huang X, Jiang W, Hu Q, Lu M, Hua ZC.
    J Mol Med (Berl); 2013 Feb; 91(2):219-35. PubMed ID: 22948392
    [Abstract] [Full Text] [Related]

  • 3. Novel histone deacetylase inhibitors derived from Magnolia officinalis significantly enhance TRAIL-induced apoptosis in non-small cell lung cancer.
    Liu Y, Tong Y, Yang X, Li F, Zheng L, Liu W, Wu J, Ou R, Zhang G, Hu M, Liu Z, Lu L.
    Pharmacol Res; 2016 Sep; 111():113-125. PubMed ID: 27268146
    [Abstract] [Full Text] [Related]

  • 4. Traditional Chinese medicine Ze-Qi-Tang formula inhibit growth of non-small-cell lung cancer cells through the p53 pathway.
    Xu Z, Zhang F, Zhu Y, Liu F, Chen X, Wei L, Zhang N, Zhou Q, Zhong H, Yao C, Zhu X, Gong C, Zhu S, Zou C.
    J Ethnopharmacol; 2019 Apr 24; 234():180-188. PubMed ID: 30660711
    [Abstract] [Full Text] [Related]

  • 5. Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner.
    Chen M, Wang X, Zha D, Cai F, Zhang W, He Y, Huang Q, Zhuang H, Hua ZC.
    Sci Rep; 2016 Oct 18; 6():35468. PubMed ID: 27752089
    [Abstract] [Full Text] [Related]

  • 6. A novel small-molecule PI3K/Akt signaling inhibitor, W934, exhibits potent antitumor efficacy in A549 non-small-cell lung cancer.
    Wang J, Wang HY, Shen Y, Liang D, Wang HY, Zhang SQ, Cao YX, Cao L.
    Anticancer Drugs; 2019 Oct 18; 30(9):900-908. PubMed ID: 30913062
    [Abstract] [Full Text] [Related]

  • 7. ER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer models.
    Kang HN, Kim SH, Yun MR, Kim HR, Lim SM, Kim MS, Hong KW, Kim SM, Kim H, Pyo KH, Park HJ, Han JY, Youn HA, Chang KH, Cho BC.
    Lung Cancer; 2016 May 18; 95():57-64. PubMed ID: 27040853
    [Abstract] [Full Text] [Related]

  • 8. T63, a new 4-arylidene curcumin analogue, induces cell cycle arrest and apoptosis through activation of the reactive oxygen species-FOXO3a pathway in lung cancer cells.
    Liu H, Zhou BH, Qiu X, Wang HS, Zhang F, Fang R, Wang XF, Cai SH, Du J, Bu XZ.
    Free Radic Biol Med; 2012 Dec 15; 53(12):2204-17. PubMed ID: 23085518
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.
    Chen S, Liu X, Yue P, Schönthal AH, Khuri FR, Sun SY.
    Mol Pharmacol; 2007 Nov 15; 72(5):1269-79. PubMed ID: 17684158
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells.
    Xiong F, Jiang M, Huang Z, Chen M, Chen K, Zhou J, Yin L, Tang Y, Wang M, Ye L, Zhan Z, Duan J, Fu H, Zhang X.
    Integr Cancer Ther; 2014 Mar 15; 13(2):152-60. PubMed ID: 24105357
    [Abstract] [Full Text] [Related]

  • 13. Effects of ebv-miR-BART7 on tumorigenicity, metastasis, and TRAIL sensitivity of non-small cell lung cancer.
    Wang L, Liu LF, Zhou L, Liao F, Wang J.
    J Cell Biochem; 2019 Jun 15; 120(6):10057-10068. PubMed ID: 30569505
    [Abstract] [Full Text] [Related]

  • 14. Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way.
    Xie J, Liu JH, Liu H, Liao XZ, Chen Y, Lin MG, Gu YY, Liu TL, Wang DM, Ge H, Mo SL.
    BMC Cancer; 2016 Nov 18; 16(1):899. PubMed ID: 27863471
    [Abstract] [Full Text] [Related]

  • 15. Sanguinarine exhibits antitumor activity via up-regulation of Fas-associated factor 1 in non-small cell lung cancer.
    Wei G, Xu Y, Peng T, Yan J, Wang Z, Sun Z.
    J Biochem Mol Toxicol; 2017 Aug 18; 31(8):. PubMed ID: 28296008
    [Abstract] [Full Text] [Related]

  • 16. In Vitro and In Vivo Antitumor Effects of Pyrimethamine on Non-small Cell Lung Cancers.
    Lin MX, Lin SH, Lin CC, Yang CC, Yuan SY.
    Anticancer Res; 2018 Jun 18; 38(6):3435-3445. PubMed ID: 29848694
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Safflower polysaccharide induces NSCLC cell apoptosis by inhibition of the Akt pathway.
    Li JY, Yu J, Du XS, Zhang HM, Wang B, Guo H, Bai J, Wang JH, Liu A, Wang YL.
    Oncol Rep; 2016 Jul 18; 36(1):147-54. PubMed ID: 27177149
    [Abstract] [Full Text] [Related]

  • 19. Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3-dependent invasion in resistant non-small cell lung cancer cells.
    Azijli K, Yuvaraj S, Peppelenbosch MP, Würdinger T, Dekker H, Joore J, van Dijk E, Quax WJ, Peters GJ, de Jong S, Kruyt FA.
    J Cell Sci; 2012 Oct 01; 125(Pt 19):4651-61. PubMed ID: 22797920
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.